Dupont Capital Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

Dupont Capital Management’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-12,159	Closed	-$291K	–	2135
2021 Q1	$291K	Sell	12,159 -2,494	-17%	-$46.4K	0.01%	1158
2020 Q4	$214K	Sell	14,653 -1,094	-7%	-$14.5K	﹤0.01%	1126
2020 Q3	$224K	Sell	15,747 -1,055	-6%	-$16.1K	﹤0.01%	1082
2020 Q2	$247K	Sell	16,802 -27,824	-62%	-$283K	0.01%	1051
2020 Q1	$184K	Buy	+44,626	New	+$209K	﹤0.01%	1043

Dupont Capital Management's GNMK Position: Q2 2021 in Review

Dupont Capital Management sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 12,159 shares — an estimated $291K sold.

Dupont Capital Management first reported a position in GNMK in Q1 2020 and held it in 5 quarters. The position peaked at $291K in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Dupont Capital Management reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Dupont Capital Management sold 12,159 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $291K.
Dupont Capital Management first reported a position in GenMark Diagnostics, Inc in Q1 2020 and held it in 5 quarters.
Dupont Capital Management's GenMark Diagnostics, Inc position peaked at $291K in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Dupont Capital Management's 13F filing for Q2 2021, filed 30 Jul 2021.